Exome Sequencing in Autistic Spectrum Disorder

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
Overall Status
Completed
CT.gov ID
NCT01059201
Collaborator
(none)
322
3
87.8
107.3
1.2

Study Details

Study Description

Brief Summary

Background:
  • Research into the genetic causes of autism spectrum disorder (ASD) involves studies of the DNA of children with autism. New DNA sequencing technology allows researchers to study specific genes in search of genetic changes that may cause or contribute to ASD. Individuals who donated DNA to the Autism Genetic Resource Exchange may benefit from further study of their DNA samples with more advanced DNA sequencing technology.

  • The role of cholesterol in individuals with ASD is currently under investigation. Research has suggested that abnormal cholesterol levels in children with autism may be related to genetic mutations or changes in how cholesterol is regulated in the body.

Objectives:
  • To study existing blood samples of children with autism spectrum disorders to evaluate the relationship between genetic traits and cholesterol function.
Eligibility:
  • Children with ASD who donated blood samples to the Autism Genetic Resource Exchange.
Design:
  • Parents/guardians of minor children with ASD will provide consent for further research to be performed on existing DNA samples in the Autism Genetic Research Exchange databank. Information from this research may be provided to the consenting parents/guardians on a case by case basis, as directed by the researchers.
Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by functional deficits in three domains: social interaction, communication, and stereotypic behavior. Prevalence has been estimated to be approximately 1/166 children and the public health impact is significant. ASD clearly has a genetic component; however, identification of specific etiologies has been complicated by the heterogeneous nature of ASD. One approach to minimize this problem is to define endophenotypes that can subcategorize ASD patients. Based on our work with Smith-Lemli-Opitz syndrome, we have investigated whether alterations in cholesterol homeostasis may contribute to ASD. We found in 200 ASD subjects that 23% of subjects had serum cholesterol levels less than or equal to 2.28th centile and 9% had levels greater than or equal to 97.72nd centile. Analysis of the sterol profile suggested that the hypocholesterolemia was due to a synthetic defect rather than decreased oral intake. Thus we hypothesize that ASD patients with abnormal cholesterol levels will have polymorphisms or mutations of either genes involved in cholesterol homeostasis or genes encoding proteins whose function is altered by changes in cholesterol levels. To test this hypothesis we propose to 1) use serum cholesterol levels to define ASD endophenotypes and 2) to perform genomic resequencing of all known exons in hypo- and normocholesterolemic ASD patients.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    322 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    Exome Sequencing in Autistic Spectrum Disorder Patients With Altered Cholesterol Homeostasis
    Study Start Date :
    Jan 21, 2010
    Study Completion Date :
    May 15, 2017

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      N/A and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      • INCLUSION CRITERIA:
      1. Prior participation in Autism Genetic Research Exchange

      2. Multiple affected children with ASD

      3. Willingness to contact the NIH and reconsent

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Kennedy Krieger Institute Baltimore Maryland United States 21205
      2 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland United States 20892
      3 Ohio State University Columbus Ohio United States 43210-1240

      Sponsors and Collaborators

      • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

      Investigators

      • Principal Investigator: Forbes D Porter, M.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      ClinicalTrials.gov Identifier:
      NCT01059201
      Other Study ID Numbers:
      • 100022
      • 10-CH-0022
      First Posted:
      Jan 29, 2010
      Last Update Posted:
      Dec 17, 2019
      Last Verified:
      May 15, 2017
      Keywords provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Dec 17, 2019